Altus Pharmaceuticals Inc (ALTUQ)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
Employees:
610 LINCOLN STREET, WALTHAM, MA 02451
781-373-6000

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

N/A

View SEC Filings from ALTUQ instead.

View recent insider trading info

Funds Holding ALTUQ (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ALTUQ

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

PRESIDIO MANAGEMENT GROUP VIII L L C

ROOT JONATHAN D

RUST CHRISTOPHER J

YOUNG PHILIP M

  • 10% Owner
No longer subject to file 2009-09-14 0

PRESIDIO MANAGEMENT GROUP VIII L L C

US VENTURE PARTNERS VIII L P

USVP VIII AFFILIATES FUND L P

USVP ENTREPRENEUR PARTNERS VIII A L P

USVP ENTREPRENEUR PARTNERS VIII B L P

CONNORS TIMOTHY J

FEDERMAN IRWIN

FU WINSTON S

KRAUSZ STEVEN M

LIDDLE DAVID E

  • 10% Owner
No longer subject to file 2009-09-14 0

PENNER HARRY JR

  • Director
0 2009-07-01 0

NAVIA MANUEL

  • Director
0 2009-07-01 0

WYZGA MICHAEL S

  • Director
0 2009-07-01 0

PENDERGAST DAVID D PHD

  • Director
0 2009-07-01 0

RICHARD JOHN P

  • Director
0 2009-07-01 0

WARBURG PINCUS PRIVATE EQUITY VIII L P

WARBURG PINCUS PARTNERS LLC

WARBURG PINCUS LLC

WARBURG PINCUS & CO

  • 10% Owner
No longer subject to file 2009-04-16 0

GEMAYEL GEORGES PRESIDENT & CEO

  • Officer
  • Director
0 2009-02-19 0

GOTWALS PHILIP VP, PROGRAM MANAGEMENT

  • Officer
0 2009-01-27 0

PHAIR THOMAS J. SR. DIR, FINANCE & CONTROLLER

  • Officer
0 2009-01-27 0

ATTIE KENNETH VP, CLINICAL DEV & MED AFFAIRS

  • Officer
0 2009-01-27 0

PORTER JILL VP, PROCESS DEV & ENGINEERING

  • Officer
0 2009-01-27 0

HEN STEWART

  • Director
  • 10% Owner
0 2008-06-12 0

LEFF JONATHAN S

  • Director
  • 10% Owner
0 2008-06-12 0

ROOT JONATHAN D

  • Director
  • 10% Owner
0 2008-06-12 0

BLANK BURKHARD EVP & CHIEF MEDICAL OFFICER

  • Officer
0 2008-05-22 0

LIEBER JONATHAN I SVP, CFO AND TREASURER

  • Officer
0 2008-05-22 0

BERKLE SHELDON PRESIDENT AND CEO

  • Officer
  • Director
479,152 2007-12-13 0

GALLOTTO ROBERT VP, STRATEGIC PLANNING

  • Officer
28,822 2007-11-01 0

MARGOLIN ALEXEY L CHIEF SCIENTIFIC OFFICER

  • Officer
135,204 2007-07-18 0

VERTEX PHARMACEUTICALS INC / MA

  • 10% Owner
3,260,770 2006-01-31 0

NOMURA INTERNATIONAL PLC

NOMURA PHASE4 VENTURES LP

NOMURA PHASE4 VENTURES LTD

NOMURA PHASE4 VENTURES GP LTD

  • 10% Owner
1,956,962 2006-01-31 0

NOMURA INTERNATIONAL PLC

NOMURA PHASE4 VENTURES LP

  • 10% Owner
1,956,998 2006-01-31 0

BRUM LYNNE H

  • Director
817,749 2006-01-31 0

WARBURG PINCUS PARTNERS LLC

WARBURG PINCUS LLC

WARBURG PINCUS & CO

  • 10% Owner
0 2006-01-25 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

No recent transactions

*** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

Elevate your investments